Judge Approves Purdue Pharma's Criminal Sentence

OxyContin maker Purdue Pharma is set to dissolve after a federal judge approved its criminal sentence, resolving thousands of lawsuits linked to the opioid crisis. According to multiple reports, U.S. District Judge Madeline Cox Arleo delivered the sentence on Tuesday in Newark, New Jersey, following hours of impact statements from victims and their families.

The settlement calls for members of the Sackler family, who own Purdue Pharma, to contribute up to $7 billion over 15 years. Most of this money will go to government entities to combat the opioid crisis. The guilty plea and civil settlement with the federal government included $8.3 billion in forfeitures, fines, and penalties.

Victims expressed frustration during the hearing, arguing that the negotiated sentence does not provide real justice. Many asked Arleo to reject the deal, citing personal losses due to opioid addiction. The judge sympathized with their plight but ultimately approved the settlement as it was the best outcome she could achieve under current legal frameworks.

Purdue Pharma admitted to deceiving government regulators and paying kickbacks to doctors to boost opioid sales. However, only the company was charged, not individual employees or owners. The settlement is among the largest in a series of settlements by drugmakers, wholesalers, and pharmacies in recent years.

The dissolution of Purdue Pharma will see it replaced by Knoa Pharma, a new company focused on combating the opioid crisis. Millions of internal Purdue documents are to be made public as part of the settlement. The Sackler family has also agreed not to object if their names are removed from museums and other institutions they have supported.